Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for your take...I am building a long term position ...buying all dips...
Cannacord Genuity 2.75 price target
https://us.v-cdn.net/5021759/uploads/OI9YXLQYOO4T/canaccord-lowl.pdf
Ok thanks for your take. My read is we have further to go on the downside toward lower supports. Chart still looks good and not expecting severe damage but the 1.75 to 1.80 support won’t hold. Expecting RSI to take a break and go sub 50. Just my technical take. All imo
Chart looks Great...Healthy expected dip to fill the Open Gap...No surprise there...
INDXF..$1.78...Gap filled on the dip...
Chart...https://schrts.co/YZhuzmgB
georgie18 Saturday, 02/27/21 06:57:03 AM
Re: georgie18 post# 18 0
Post #
22
of 33
INDXF...$1.92...Pierced the Upper Consolidation Channel...Psar flipped to a Bullish Buy Position...Leaving an Open Gap in the $1.80 range...
Blue Skies Chart with the Last Resistance in the $11 range...Break/Hold $11 range and we have NO Topside Resistance...
Yeah. That earnings release was scary.
I was shocked it held up in the 2.40s as long as it did before selling off into the close. I. need to listen to the cc but apparently Q1 guidance is equally awful. These guys are now creating a very poor pattern of quarterly operational disappointments. The 225K house was supposed to be in order by end of Q1 churning out 42K lbs of product on an annualized basis. George has trusted Mark on the operational side perhaps too much. Hoping George doesn’t have a blind spot as he is always looking downfield while quarterly disappointments accrue. I almost peeled off some of my cores yesterday and put on a short but I like this Lowell move a whole lot. It positions this company to move toward “one of the Cali leaders” category over the intermediate term and thus the stock should trade closer toward a leader valuation metric if/when they get their house in order. For now the path of least resistance is sideways to down toward supports (unless the sector catches fire with more decriminalization news) All imo.
The quarterly earnings were abysmal but the investment community must see something here.
Nice trade! A quick 10% win is nothing to sneeze at. This stock has been a lot of fun to trade the last few months. A scalpers dream although at times a bit illiquid.
Added this a.m. @ $1.74
It looks like a Breakdown out of a rising channel. Now moving up to backtest the breakdown. Looks bearish for now. I’m saving my trading pennies to see how it tests recent supports. All imo
George,How is your chart looking now? I dumped my traders yesterday when I saw the MFI and RS divergence on the daily. I do not like to see 52 week highs met with lower MF and RS especially going into earnings. I’m still holding cores. Fundamentally, EV is a bit rich here at around probably 4X 21 sal3s. so I’m thinking pullback to some recent supports but I need to listen to the archived cc and get a better understanding. The earnings were frankly awful on a QoQ basis.
Lowell Farms Inc., Formerly Known as Indus Holdings, Inc., Announces Fourth Quarter and Fiscal Year 2020 Results
03/02/2021
SALINAS, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: INDS converting to LOWL; OTCQX: INDXF to LOWLF effective March 5, 2021), a leading, vertically-integrated, California-focused cannabis company, announced revenue and operating results for the fourth quarter and fiscal year (ended December 31, 2020). All figures stated are in US Dollars.
Fourth Quarter and Fiscal Year Financial Highlights:
Revenue generated for the three-month period ended December 31, 2020, was $9.2 million; a decline of 15% from the fourth quarter last year. Revenue for the year ended December 31, 2020, was $42.6 million; 15% year-over-year growth.
Adjusted EBITDA for the three-month period ended December 31, 2020, was ($3.7 million) compared to ($13.2 million) in the fourth quarter last year; Adjusted EBITDA for the year-end December 31, 2020, was ($9.8 million) compared to ($36.0 million) in 2019. See “Use of Non-IFRS Financial Information” below.
Operating expenses were $5.5 million for the three-month period ended December 31, 2020, compared to $12.0 million in the fourth quarter in the prior year. For the year ended December 31, 2020, operating expenses were $20.6 million; a decline of 45% from 2019.
Gross margin (before net change in fair value of biological assets) of 8% compared to negative margin of 40% in the fourth quarter last year. For the year ended December 31, 2020, gross margin (before net change in fair value of biological assets) was 11% compared to negative margin of 23% in 2019. See “Use of Non-IFRS Financial Information” below.
Operating loss before net change in fair value of biological assets of $4.8 million compared to operating loss of $14.0 million in Q4 2019. For the year ended December 31, 2020, operating loss before net change in fair value of biological assets was $16.1 million compared to an operating loss before net change in fair value of biological assets of $45.8 million in 2019. See “Use of Non-IFRS Financial Information” below.
The declined revenue and operating results in the quarter are primarily the direct result of suppressed cultivation yields resulting from the wildfires and extreme temperatures in late summer, and the resultant plant stress that ensued.
“Despite the headwinds encountered last year, we have much to look ahead and our shift in strategy to acquire Lowell Herb Co and become Lowell Farms will position us for the future,” says Mark Ainsworth, Chief Executive Officer for Lowell Farms Inc. “Our team has shown tenacity and drive to get to where we are, and I know what we are capable of achieving when all cylinders are turned on and we are executing to the best of our capacities.
“The future is bright for Lowell Farms and I can’t wait to share more with you as we solidify our positioning within the California market.”
Operational Highlights and Ongoing Initiatives in 2021:
The Company’s focus and strategic planning of key initiatives continue to drive sustainable profitable growth, with top priorities on its cultivation facilities, improving operational efficiency, and refinement of biological assets.
Cultivation Quality and Efficiency:
As the Company continues to evaluate its cultivation processes, refine genetics, and enhance facilities and systems, the focus has been on improving the output.
The Company successfully completed the electrical, mechanical, and environmental upgrades with final approval from the county in the quarter. The environmental upgrades will help mitigate implications experienced from the wildfires and extreme temperatures experienced in the summer.
Lowell Farms is actively exploring tissue culture clones in order to expand and refine its strain selection.
Portfolio of strains coming from the newly improved cultivation have consistently tested in the mid to high 20's for THC potency.
Continued yield improvements are expected to be seen as the environmental control system has been installed and implemented.
In Q4, Indus commissioned an automated flower packaging line which meant an immediate 61% reduction in flower packing headcount.
When fully optimized, the reduction will generate two times the productivity from 50 lbs. per shift to 100 lbs. per shift.
Owned Core Brands:
Owned brands continue to gain market share by strategically expanding in a variety of categories in the fourth the quarter of 2020:
Flavor was the number four Concentrate brand in Q4 2020 and single handedly made up 6% of all concentrate units sold during Q4 2020.
Expanding portfolio of products:
The Company is working on expanding existing brands into new categories while also growing its brand portfolio to engage with new consumers and create additional revenue streams.
We launched 11 net new sku’s.
Distribution Capabilities:
In an effort to simplify and refocus the business on owned brands, the Company has continued to move away from the agency and distribution aspects of its business.
In order to process the increased flower from its renovated cultivation, Indus has submitted for a cultivation and processing license application for warehouse facilities. Plans for construction of the post-harvest processing space are underway and have been submitted and approved by the City.
Q4 and Fiscal Year Financial Results Earnings Conference Call Details:
The conference call with management at 8:30 a.m. ET on Tuesday, March 2, can be accessed using the following dial-in information:
U.S. and Canadian Toll Free: 1-877-407-0789
International: 1-201-689-8562
Conference ID: 13716552
Webcast: public.viavid.com/index.php?id=143565
Please dial-in at least 10 minutes before the call to register.
The conference call will be webcast live and archived on the investor relations section of the Lowell Farms website at https://ir.indusholdingco.com/.
ABOUT LOWELL FARMS
Lowell Farms (CSE:LOWL; OTCQX:LOWLF) is California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain; including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Founded in 2014 as Indus Holdings, Inc, Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning original and licensed brands, including Lowell Herb Co, Cypress Cannabis, MOON, Humble Flower, and Kaizen Medicinals, for licensed retailers statewide.
INDXF...$2.12s clearing here on the Upper Bollie push...off my $1.05 alert...:party:
INDXF...$1.92...Pierced the Upper Consolidation Channel...Psar flipped to a Bullish Buy Position...Leaving an Open Gap in the $1.80 range...
Blue Skies Chart with the Last Resistance in the $11 range...Break/Hold $11 range and we have NO Topside Resistance...
georgie18 Friday, 02/26/21 04:27:17 AM
Re: georgie18 post# 6 0
Post #
18
of 21
INDXF...$1.77...Consolidation Channel Breakout Setting up here...imo...we shall see...
Chart... https://schrts.co/AVuquCms ...
First alerted on this News...georgie1812/21/2020
INDXF...$1.05...SALINAS, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. (“Indus” or the “Company”) (CSE:INDS; OTCQX:INDXF), a leading, vertically-integrated, California-focused cannabis company announces the closing of its previously announced underwritten public offering (the “Offering”) of units of the Company (the “Units”). The Offering was conducted by a syndicate of underwriters co-led by Canaccord Genuity Corp. and Beacon Securities Limited, and including PI Financial Corp. (collectively, the “Underwriters”) and consisted of the sale of 23,000,000 Units (including the full exercise of the over-allotment option by the Underwriters) at a price of C$1.50 per Unit (the “Offering Price”) for aggregate gross proceeds of C$34,500,000,...
we don't have much scratch laying around but what we had around we tossed this way. Lowell Farms #ftmfw https://t.co/mNJtP7JwSd
— Todd Harrison (@todd_harrison) February 26, 2021
CANNABIS STOCKS TOP 10
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. On the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically, will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1)TILT TLLTF HOLD ADD
2)High Tide HITIF HOLD ADD
3)Harvest Health HRVSF HOLD ADD
4)Columbia Care CCHWF HOLD ADD
5)INDDUS Holdings INDXF NEW
6)CRESCO CRLBF HOLD
7)Verano Holdings VRNOF NEW NO POSITION
8)TerrAscend TRSSF NO POSITION
9)4Front FFNTF HOLD
10)AYR Resources AYRWF SOLD
11)Green Thumb GTBIF SOLD
12)HEXO HEXO SOLD
13)Schwazze SHWZ NO POSITION
14)Jushi JUSHF SOLD
15)Trulieve TCNNF NO POSITION
16)HOLLISTER HSTRF SOLD
17)GrowGeneration GRWG NO POSITION
18)Curaleaf CURLF SOLD
19)TILRAY TLRY SOLD
20)TPCO Holding Inc GRAMF SOLD
TOP 5 INDEX START $28.80 2/25 $ _________
Interview w/ George Allen at the 5.06 mark
INDXF...$1.77...Consolidation Channel Breakout Setting up here...imo...we shall see...
Chart... https://schrts.co/AVuquCms ...
Indus Holdings Bets Big on Building Large-Scale Cannabis Cultivation in California
December 23, 2020
Exclusive article by Carrie Pallardy
Exclusive Interview with Indus Holdings Chairman George Allen
Indus Holdings (CSE: INDS) (OTC: INDXF) is seeking to stand out in the cannabis space through scale in California. In March, George Allen led a recapitalization of the business and stepped into the chairman role. He spoke with New Cannabis Ventures about the company’s mission, expansion plans and opportunities in California.
The audio of the entire conversation is available at the end of this written summary.
https://soundcloud.com/newcannabisventures/indus-holdings-bets-big-on-building-large-scale-cannabis-cultivation-in-california
The New Chairman
Allen entered the cannabis space as an investor in 2016. He observed a lack of organization in the industry and decided to get more directly involved. He joined High Street Capital Partners, the predecessor of Acreage Holdings, working as CFO and then president of the company. He took the company through several layers of financing and going public, leaving right before the transaction with Canopy Growth.
As Chairman of Indus, Allen has put forth a simple mission: focus. He wants to see the company become the best at what it does in California. While there is a lot of hype around building brands and brand equity, data indicates consumers buy based on value, according to Allen. So Indus is driven to deliver more for less, bringing consumers quality products at a great price.
Rather than adopting an MSO model, the company intends to remain focused on California until it becomes the market leader in the state.
The Indus Team
Allen highlighted a robust leadership team, starting with CEO Mark Ainsworth. Ainsworth has an exceptional talent for motivating employees and driving teams to work for a common cause, according to Allen. Brian Shure recently stepped into the CFO position, while Steve Neil serves as VP of Finance. Jenny Montenegro, previously with Costco, serves as COO. Indus also has strong cultivation and sales teams, according to Allen.
California Footprint and Expansion
Indus is based in Salinas, an attractive place to grow cannabis. The company cultivates, manufactures and distributes its own products. Currently, you can drive from one end of the company to the other in about 15 minutes, according to Allen. He has found this invaluable, allowing leadership to be in one place and quickly make decisions.
The Company’s Current Cultivation Operations
While the company may be centralized right now, it has announced major expansion plans that will spread its operations to multiple facilities in the surrounding area. The initial phase of the expansion plan will bring on board a 300,000-square-foot facility in Monterey County.
Indus is growing its footprint with the ultimate goal of becoming the largest cultivator in the United States. As it adds new facilities, it will bring its technical knowledge to upgrade their capabilities and grow output levels by four to six times, according to Allen.
Allen’s background makes M&A an appealing option, but he acknowledges that acquisitions can be challenging in the cannabis space. Indus will not pursue any deals that do not align with its values or deals that will negatively impact the balance sheet with a poor cash structure. While there may be deals that do make sense, Allen also sees a lot of potential for continued organic growth.
The Equity Opportunity
Indus completed a C$34.5 million equity offering in December. The company has a fairly clean balance sheet, according to Allen. It has a lease obligation on its existing cultivation facility, and it has a convertible debt instrument.
Allen favors equity over debt, considering debt a risky decision for companies still in their early stages of growth. Allen is aligned with the company’s investors. He is a significant investor in Indus, leading the recapitalization of the company in the spring and buying more shares in the latest offering at a substantially higher price.
When he stepped into the chairman role and recapitalized the business, Allen brought with him a number of historical investors. Now, Indus has built a compelling book with participation from approximately 35 institutions, according to Allen.
While stock prices will go up and down in the cannabis industry, Allen is more focused on the long view than daily fluctuations. He places more importance on the volume of stock, which indicates an ability to access the capital markets for growth opportunities. Allen is pleased with the volume and amount of participation that came with the company’s latest offering.
Capital Allocation Strategy
With the cash on hand from the recent offering, the company is looking to expand its cultivation operations. Allen wants to build a moat around the business, creating and scaling a differentiated position that will protect the company when capital becomes more abundant in the space.
Indus is one of the only companies committed to large scale cultivation in California, which will give the company a number of advantages, according to Allen. He sees the company being able to drive down marginal prices and negotiate favorable tax treatment with local jurisdictions.
As the company continues to grow, Allen wants the balance sheet to remain clean. Indus is committed to taking on capital projects that are fully funded from the outset. The latest expansion announcement is broken into steps built around the company’s ability to raise capital.
Expanding Its Cultivation Capabilities Is the Biggest Opportunity Ahead of Indus.
Expanded cultivation output will help the company to power its product manufacturing and distribution engine, pushing more CPG products into dispensaries. Allen hopes to see improved dispensary penetration in the year ahead.
Challenges
Indus has not weathered 2020 without challenges. The wildfires in California caused the company to release revised Q4 guidance. The company suffered compromised yields, and it is seeking business interruption and crop failure insurance recovery, according to Allen. In the meantime, the company has made changes to its greenhouse operations to handle this type of challenge should it occur again.
In addition to the wildfires, Indus is contending with the COVID-19 pandemic, along with the rest of the industry. The company has had employees get sick, and it has worked hard to put protocols in place to keep operations running as safely and smoothly as possible.
2021 Outlook and Opportunities
While 2020 has been a challenging year, Allen sees opportunities ahead in 2021. The company’s current greenhouse is operating at about half capacity right now, but the team expects it to reach its full capacity through the course of next year. Additionally, increased penetration with its CPG products will help to drive revenue.
Indus Aims to Drive Revenue with Increased CPG Product Penetration.
Indus has a series of approximately 40 metrics it continuously monitors and a compensation matrix that aligns its employees with the ones for which they are responsible. In the greenhouse, the company tracks metrics like harvest yield and potency levels. On the sales side, it looks at KPIs like the number of dispensaries served, sales density per dispensary and average order size. It also manages manufacturing metrics like product yields and total cost.
Unlocking the potential of its current operations and its expanding footprint are the biggest opportunities ahead of Indus, according to Allen. The company has raised enough capital to take the first step in its expansion plan, and it will nurture its relationship with the capital markets to continue moving forward.
With the potential for major regulatory changes to open the door to interstate commerce on the horizon, Allen anticipates that many cannabis MSOs are going to focus more effort on cultivation in California, but Indus will have a head start with an established high-quality, low-cost cultivation footprint in the state.
Canada's Indus Holdings buys Miley Cyrus-backed pot producer
BY Reuters
Feb 25, 2021
Pot producer Indus Holdings Inc ( INDXF ) said on Thursday it bought California-based rival Lowell Herb Co for $39 million, adding a brand backed by Miley Cyrus and Chris Rock to its offering of products.
Consolidation is heating up in the cannabis sector as companies pursue scale to benefit from the coronavirus-driven surge in weed sales and likely relaxation of U.S. federal prohibitions after Joe Biden's win in the presidential election.
Canadian pot producer Aphria Inc ( APHA ) said in December it would merge with rival Tilray Inc ( TLRY ), creating the world's largest cannabis producer by sales.
Indus paid $4.1 million in cash and issued 22.6 million shares to Lowell Herb, which also raised money from celebrities such as Mark Ronson and Sarah Silverman.
The Canadian company plans to change its name to Lowell Farms Inc.
It also said that Lowell Herb-owner, The Hacienda Group, would continue to produce the brand's products, which include smokes, cannabis flowers, oil and vapes, for an interim period.
(Reporting by Rithika Krishna in Bengaluru; Editing by Aditya Soni)
Thanks for posting that.
I got a starter position yesterday. Nice start to that.
Lowell Farms is an excellent well known brand, at least in California
https://d1io3yog0oux5.cloudfront.net/_4d46cbb35b0e100b9214893cc1eb2123/indusholdingco/db/641/5326/pdf/Lowell+Farms+Transaction+Presentation.pdf
Great podcast about merger with Lowell
https://seekingalpha.com/article/4408879-billion-dollar-cannabis-brand-podcast
CANNABIS STOCKS TOP 10
02/25/2021
My criteria;
#1. I like to see at least 100M in annual sales.
#2. I like to see an outstanding share number of less than 300M.
#3. The stock must have momentum. Especially right now.
#4. The company should be on the way to EBITDA break-even, if not there yet.
#5. Maybe a turnaround story, or legit, right out of the box.
#6. Typically, will be focused on the U.S., not Canada.
#7. For now, will be marijuana only. No hemp.
1)TILT TLLTF BOUGHT Last week (19)
2)High Tide HITIF HOLD ADD
3)Harvest Health HRVSF HOLD ADD
4)Columbia Care CCHWF BOUGHT
5)CRESCO CRLBF HOLD ADD
6)Verano Holdings VRNOF NEW
7)TerrAscend TRSSF NO POSITION
8)4Front FFNTF HOLD ADD LW (10)
9)AYR Resources AYRWF SOLD
10) INDUS Holdings INDXF NEW
11)Green Thumb GTBIF SOLD
12)HEXO HEXO SOLD
13)Schwazze SHWZ NO POSITION
14)Jushi JUSHF SOLD
15)Trulieve TCNNF NO POSITION
16)HOLLISTER HSTRF BOUGHT
17)GrowGeneration GRWG NO POSITION
18)Curaleaf CURLF SOLD
19)TILRAY TLRY SOLD
20)TPCO Holding Inc GRAMF SOLD
Indus Holdings, Inc. Reports Record Third Quarter 2020 Results
Press Release
11/09/2020
Company delivers strong results despite being adversely affected by California Wildfires
Vertically-integrated California cannabis leader reports highest revenue quarter since its inception
SALINAS, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus” or the “Company”) (CSE:INDS; OTCQX: INDXF), a leading, vertically-integrated, California-focused cannabis company, announces its financial results for the third quarter ended September 30, 2020 following the previously released preliminary financial highlights. All figures stated are in US Dollars.
Third Quarter Financial Highlights:
Revenue generated for the three-month period ended September 30, 2020, was $14.1 million; a 40% year-over-year growth from the third quarter last year and an increase of 43% from the prior quarter. As a percentage of revenues, owned brands grew from 73% in the prior quarter to 84% in the third quarter.
EBITDA for the three-month period ended September 30, 2020, was $2.3 million; EBITDA for the previous quarter ended June 30, 2020, was ($3.9 million). Note that previously reported negative EBITDA for the quarter ended June 30, 2020 was ($3.3 million), which has been corrected to properly reflect investment gains in the quarter. See “Use of Non-IFRS Financial Information” below.
Net income for the three-month period ended September 30, 2020, was $2.4 million, compared to a net loss of ($4.8 million) in the second quarter.
Adjusted gross margin (before net change in fair value of biological assets) of 41.5% compared to negative margin of (9%) in Q2 2020. See “Use of Non-IFRS Financial Information” below.
Operating income before net change in fair value of biological assets of $1.0 million compared to operating loss of ($5.2 million) in Q2 2020. See “Use of Non-IFRS Financial Information” below.
Operating result improvements from the previous quarter reflects strategic product mix improvements as increased flower volumes were realized and the continuing impact from cost reduction efforts.
Impact of California Wildfires:
During Q3 the Company experienced harvest weights that were on average 20% below Q2 levels. The company attributes the declines to remediation measures the Company adopted to avoid crop-loss during the wildfires.
The Company did increase in total flower harvest volumes during the quarter due to the increased number of harvests resulting from the expansion efforts in the first half of the year.
The Company is implementing automated environmental controls to mitigate similar losses in the future.
Indus expects that harvest yields will remain suppressed into the fourth quarter as we work through the plants in the greenhouse that were impacted by the remediation measures.
“Despite the headwinds caused by the wildfires, our Q3 results are the direct result of a strategy that prioritizes increased cultivation output and the Indus family of owned products,” says Mark Ainsworth, Chief Executive Officer for Indus Holdings, Inc. “While exceeding our expectations for the quarter, our performance was well short of where we could have been but for the impact of the wildfires and we are taking steps to be better prepared in the future.”
Operational Highlights and Ongoing Initiatives in 2020:
The Company showcased expected positive results due to the focus and strategic planning of key initiatives that are continuing to drive sustainable profitable growth, with top priorities of finalizing renovation of its cultivation facilities, improving operational efficiency, and refinement of biological assets.
California Cultivation Facility Build-out:
The Company has completed its greenhouse renovations bringing it to 29 active flower rooms. These renovations added 110,000 square feet bringing the current total cultivation to approximately 185,000 square feet.
The nursery renovation has been completed. This upgrade allows Indus to maximize square footage in the flowering rooms and maintain consistency throughout.
Successfully completed the majority of electrical, mechanical, and environmental upgrades with final approval from the county.
Plans for renovation of processing space underway and new dry rooms have been submitted for permitting with the county.
Cultivation Quality and Efficiency:
Indus portfolio of strains coming from the newly improved cultivation have consistently tested in the mid to high 20's and low 30's for THC potency.
Continued improved cultivation processes, refined genetics, and enhanced facilities and systems have led to a consistent increase in potency and yields.
Indus is actively exploring tissue culture clones in order to expand and refine its strain selection.
The Company is implementing advanced Environmental Control systems that are customized and adaptable. Expected completion is December 2020.
Continued yield improvements are expected to be seen as the environmental control system is installed.
In October, Indus commissioned our automated flower packaging line which will improve production time and speed to market while reducing labor costs.
Indus Owned Core Brands:
Indus owned brands continue to gain market share by strategically expanding in a variety of categories in the third the quarter of 2020:
Flavor grew 71% from Q2 to Q3.
Original Pot Co. successfully launched two additional new baked good SKUs in Q3 and grew 42% from Q2. Allowing the team to penetrate in over 70 net-new dispensaries and garnered the highest month of revenue for the brand to date.
Moon, a chocolate edible brand, continues its position in the top three highest selling brands in cannabis-infused chocolates according to BDS Analytics.
Moon launched four different SKU’s from its highly anticipated gummy line, the first expansion into gummies for the brand.
Cypress brand sales grew by 42% from Q2 to Q3.
Due to our cultivation producing higher quality flower, Indus’ flower continues to fill the void in the market for a higher demand in potency at a competitive price.
Indus’ expanding portfolio of brands:
Indus is working on expanding existing brands into new categories while also growing its brand portfolio to engage with new consumers and create additional revenue streams.
Distribution Capabilities:
Since bringing distribution technologies in house, Indus has improved its processing and ordering technology to maximize revenue and provide world-class service.
Deliveries to dispensaries per day increased by 11% from Q2 to Q3.
Average delivery value increased by 19% from Q2 to Q3.
In order to process the increased flower from its renovated cultivation, Indus has submitted for a cultivation and processing license application for warehouse facilities. Plans for construction of the post-harvest processing space have been submitted to the City.
“The turnaround at Indus has been the result of huge efforts by a highly talented team,” said George Allen, Chairman of the Board of Indus Holdings, Inc. “Not only has Indus solidified its market position as a dominant force in the cannabis industry, but the organization has positioned itself for greater success in the coming fiscal year.
Q3 Financial Results Earnings Conference Call Details:
The conference call with management at 8:30 a.m. ET on Tuesday, November 10 can be accessed using the following dial-in information:
U.S. and Canadian Toll-free: 1-877-407-0789
International: 1-201-689-8562
Conference ID: 13712405
Please dial-in at least 10 minutes before the call to register.
The conference call will be webcast live and archived on the investor relations section of the Indus Holdings, Inc. website at https://ir.indusholdingco.com/.
ABOUT INDUS HOLDINGS, INC
Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF) is a vertically-integrated cannabis company with advanced production capabilities, including cultivation, extraction, manufacturing, brand sales & marketing, and distribution. Founded in 2014 and based in Salinas, California, Indus offers services supporting every step of the supply chain and an extensive portfolio of award-winning brands, including Cypress Cannabis, House Weed, The Original Pot Co., MOON, Humble Flower, and Kaizen Medicinals. Indus Distribution, a division of Indus Holdings, Inc., is a leading distributor of cannabis products, servicing an extensive portfolio of brands and licensed retailers.
Indus will change its corporate name to Lowell Farms Inc. and company will trade under ticker LOWL.
Outstanding Shares
44,849,785
02/17/2021
The Ceo wants to see the company become the best at what it does in California. While there is a lot of hype around building brands and brand equity, data indicates consumers buy based on value, according to Allen. So Indus is driven to deliver more for less, bringing consumers quality products at a great price.
Rather than adopting an MSO model, the company intends to remain focused on California until it becomes the market leader in the state.
Great way to learn about Indus
https://www.newcannabisventures.com/indus-holdings-bets-big-on-building-large-scale-cannabis-cultivation-in-california/
INDXF...$1.05...SALINAS, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. (“Indus” or the “Company”) (CSE:INDS; OTCQX:INDXF), a leading, vertically-integrated, California-focused cannabis company announces the closing of its previously announced underwritten public offering (the “Offering”) of units of the Company (the “Units”). The Offering was conducted by a syndicate of underwriters co-led by Canaccord Genuity Corp. and Beacon Securities Limited, and including PI Financial Corp. (collectively, the “Underwriters”) and consisted of the sale of 23,000,000 Units (including the full exercise of the over-allotment option by the Underwriters) at a price of C$1.50 per Unit (the “Offering Price”) for aggregate gross proceeds of C$34,500,000,
INDXF...$1.17...Volume pouring in here...40,000 share buy at $1.17...:party:
INDS.CA the US weedster is about to blow up!!!
INDS.CA the only weedster I like ...here we go!!
INDXF/INDS.CA A US weedster ready to rumble.!! Extremely undervalued!!
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
189
|
Created
|
05/09/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |